Cargando…
Loss of Central Auditory Processing in a Mouse Model of Canavan Disease
Canavan Disease (CD) is a leukodystrophy caused by homozygous null mutations in the gene encoding aspartoacylase (ASPA). ASPA-deficiency is characterized by severe psychomotor retardation, and excessive levels of the ASPA substrate N-acetylaspartate (NAA). ASPA is an oligodendrocyte marker and it is...
Autores principales: | von Jonquieres, Georg, Froud, Kristina E., Klugmann, Claudia B., Wong, Ann C. Y., Housley, Gary D., Klugmann, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020830/ https://www.ncbi.nlm.nih.gov/pubmed/24826990 http://dx.doi.org/10.1371/journal.pone.0097374 |
Ejemplares similares
-
Dual-function AAV gene therapy reverses late-stage Canavan disease pathology in mice
por: Fröhlich, Dominik, et al.
Publicado: (2022) -
Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy
por: von Jonquieres, Georg, et al.
Publicado: (2017) -
Recombinant Human Myelin-Associated Glycoprotein Promoter Drives Selective AAV-Mediated Transgene Expression in Oligodendrocytes
por: von Jonquieres, Georg, et al.
Publicado: (2016) -
Glial Promoter Selectivity following AAV-Delivery to the Immature Brain
por: von Jonquieres, Georg, et al.
Publicado: (2013) -
Aspartoacylase-LacZ Knockin Mice: An Engineered Model of Canavan Disease
por: Mersmann, Nadine, et al.
Publicado: (2011)